About Person
Univ.-Prof. Dr. rer. nat. Edgar Dahl
Tel.: +49 241 80-88431
Fax: +49 241 80-82439
edahlukaachende
Curriculum vitae
Prof. Dr. Edgar Dahl (PhD)
Institute of Pathology
University Hospital of the RWTH Aachen
- Head Molecular Oncology Group
- Head Molecular Pathology
- Scientific director of the RWTH centralized
Biomaterial Bank (RWTH cBMB)
Core Expertise and Research Focus
- Characterization of novel class II tumor suppressor genes (C2TSGs) in breast and pancreatic cancer
- Deciphering the clinical relevance of C2TSGs ITIH5 and SFRP1 in human cancers
- Research into the therapeutic application of ITIH5 and SFRP1 proteins and small molecule mimetics
Career Summary
2004 - today:
Institute of Pathology, RWTH Aachen University
Function: see above
1997 – 2003:
metaGen Pharmaceuticals Berlin (former Schering AG subsidiary)
Function: Head of Section Gynecological Cancer
1994 – 1997:
GSF Research Center Munich; Institute of Mammalian Genetitcs
Function: Postdoc position with Prof. Rudi Balling
1990 – 1994:
University of Bonn – Institute of Genetics and Molecular Genetics
Function: PhD position with Prof. Klaus Willecke
Education
- Habilitation in Molecular Pathology, Rheinisch-Westfälische Technische Hochschule Aachen, Germany, 2006
- Doctor in Biology (Ph.D.), Rheinische-Friedrich-Wilhelms-Universität Bonn, Germany, 1994
Teaching
- Organization and contribution to the lecture series "Applied Molecular Medicine (AMM)"
- Organization and contribution to the practical training "Applied Molecular Medicine" (AMM-P)
- Contribution (lectures, exams) to the "Modellstudiengang" of the Medical Faculty, RWTH Aachen
- Member of the MD/PhD commission of the Medical Faculty, RWTH Aachen
Publications
> 150 original publications and reviews in cancer research and molecular and cellular biology
> h-index: 56